Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 10 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CELGENE CORP /DE/ | 692,192 | reported | 13 Jan 2011 | tx 114+5,219,053−6,687,948 |
| CervoMed Inc. | 123,287 | reported | 24 Jul 2014 | tx 16+1,584,461−552,728 |
| NexImmune, Inc. | 44,983 | reported | 05 Jul 2023 | tx 34+3,768,230−2,445,091 |
| CONTRAFECT Corp | 42,000 | reported | 17 May 2022 | tx 4+127,000 |
| Avalo Therapeutics, Inc. | 40,000 | reported | 15 Jun 2021 | tx 4+1,565,000 |
| InspireMD, Inc. | 20,000 | reported | 07 Dec 2016 | tx 48+18,274,377−3,345,573 |
| AMICUS THERAPEUTICS, INC. | 20,000 | reported | 09 Jun 2016 | tx 11+190,000 |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | 10,863 | reported | 28 May 2026 | tx 33+639,101−210,772 |
| Aegerion Pharmaceuticals, Inc. | 0 | reported | 29 Nov 2016 | tx 14+100,383−120,359 |
| PDS Biotechnology Corp | 0 | reported | 15 Mar 2019 | tx 18+798,075−836,710 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 10,863 | 0.00 USD | deriv |
| 06 Jun 2025 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 17,158 | — | |
| 06 Jun 2025 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 17,158 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 21,739 | 0.00 USD | deriv |
| 15 Jun 2024 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 37,598 | — | |
| 15 Jun 2024 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 37,598 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 17,158 | 0.00 USD | deriv |
| 04 Aug 2023 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 28,162 | — | |
| 04 Aug 2023 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 28,162 | 0.00 USD | deriv |
| 05 Jul 2023 | GRANT_AWARD | NexImmune, Inc. | 44,983 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 37,598 | 0.00 USD | deriv |
| 04 Apr 2023 | GRANT_AWARD | NexImmune, Inc. | 155,900 | — | deriv |
| 04 Apr 2023 | OTHER | NexImmune, Inc. | 155,900 | — | deriv |
| 04 Apr 2023 | GRANT_AWARD | NexImmune, Inc. | 19,113 | — | deriv |
| 04 Apr 2023 | OTHER | NexImmune, Inc. | 61,678 | — | deriv |
| 04 Apr 2023 | GRANT_AWARD | NexImmune, Inc. | 61,678 | — | deriv |
| 04 Apr 2023 | OTHER | NexImmune, Inc. | 19,113 | — | deriv |
| 30 Mar 2023 | PURCHASE | NexImmune, Inc. | 400,000 | 0.41 USD | |
| 16 Nov 2022 | PURCHASE | NexImmune, Inc. | 125,000 | 0.48 USD | |
| 17 Nov 2022 | PURCHASE | NexImmune, Inc. | 75,000 | 0.48 USD | |
| 04 Aug 2022 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 28,162 | 0.00 USD | deriv |
| 14 Jun 2022 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 25,791 | — | |
| 14 Jun 2022 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 25,791 | 0.00 USD | deriv |
| 13 Jun 2022 | GRANT_AWARD | NexImmune, Inc. | 61,678 | 0.00 USD | deriv |
| 01 Jun 2022 | PURCHASE | NexImmune, Inc. | 40,000 | 2.35 USD |
3 purchases reported after at least 12 months of silence — most recent on 18 Mar 2022.